The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial
Abstract
Objective: To investigate the efficacy of dexamethasone inner ear perfusion by intratympanic injection in hearing loss, tinnitus, aural fullness, and vertigo in the treatment of unilateral Ménière's disease and compare it with the control group. Study Design and Setting: A prospective, randomized, double‐blind study with 2‐year follow‐up comparing changes secondary to dexamethasone inner ear perfusion versus placebo consisting of saline solution. Patients: Twenty‐two patients having definite Ménière's disease as outlined by the 1995 American Academy of Otolaryngology‐Head and Neck Surgery Committee on Hearing and Equilibrium. All the patients were older than 18 years of age and were not receiving any other form of treatment with steroids for their Ménière's disease. Method: Five consecutive daily intratympanic injections of dexamethasone or placebo to the involved ear. Results: In the dexamethasone group at 2‐year follow‐up, complete control of vertigo (class A) was achieved in 9 of 11 patients (82%) and substantial control of vertigo (class B) in the remaining 2 patients (18%.) In the control group only 7 of 11 patients (64%) finished the 2‐year follow‐up because in the other 4 patients (36%) we had to give another treatment for the continuing vertigo and thus they were classified as failure (class F.) From the 7 patients who have finished the follow‐up of 2 years in the control group, 4 patients (57%) achieved class A, 2 patients (29%) achieved class C, and 1 patient (14%) class F. Conclusions: Dexamethasone (4 mg/mL) inner ear perfusion in a group of patients with unilateral Ménière's disease (Shea's stage III) showed 82% of complete control of vertigo over placebo (57%). There was also a subjective improvement in tinnitus (48%), hearing loss (35%), and aural fullness (48%) in the dexamethasone group compared with 20%, 10%, and 20% respectively in the control group. EBM Rating: A
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parnes, L. S., Sun, A., & Freeman, D. J. (1999) · The Laryngoscope · doi:10.1097/00005537-199907001-00001 · Cited by 634
Cited by
Sajjadi, H., & Paparella, M. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61161-7 · Cited by 583
Nakashima, T., Pyykkö, I., Arroll, M. A., Casselbrant, M. L., Foster, C. A., Manzoor, N. F., Megerian, C. A., Naganawa, S., & Young, Y.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.28 · Cited by 323
Clinical Practice Guideline: Ménière’s Disease
Basura, G. J., Adams, M. E., Monfared, A., Schwartz, S. R., Antonelli, P. J., Burkard, R., Bush, M. L., Bykowski, J., Colandrea, M., Derebery, J., et al. (2020) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599820909438 · Cited by 316
Metadata
- Authors
- Garduño‐Anaya, M. A., De Toledo, H. C., Hinojosa‐González, R., Pane‐Pianese, C., & Ríos‐Castañeda, L. C.
- Venue
- Otolaryngology–Head and Neck Surgery
- Publisher
- Wiley
- Published
- 2005-08
- Volume
- 133
- Issue
- 2
- Pages
- 285-294
- ISSN
- 0161-6439 (ISSN-L)
- 0194-5998
- 1097-6817
- OpenAlex
- W2110001084
- Cited by
- 217
- References
- 1
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial. https://app.cochat.ai/papers/10.1016/j.otohns.2005.05.010
- The paper
- Garduño‐Anaya, M. A., De Toledo, H. C., Hinojosa‐González, R., Pane‐Pianese, C., & Ríos‐Castañeda, L. C. (2005). Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1016/j.otohns.2005.05.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.